{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:10:53Z","timestamp":1770109853401,"version":"3.49.0"},"reference-count":0,"publisher":"The Medical Letter, Inc.","issue":"1746","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Lett Drugs Ther"],"abstract":"<jats:p>The FDA has approved Tonmya (Tonix), a sublingual tablet formulation of the skeletal muscle relaxant cyclobenzaprine, for treatment of fibromyalgia in adults. Cyclobenzaprine is available in immediate-release tablets and extended-release capsules for short-term treatment of muscle spasms and has been used off-label for treatment of fibromyalgia.<\/jats:p>","DOI":"10.58347\/tml.2026.1746a","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:26:23Z","timestamp":1770063983000},"page":"9-10","source":"Crossref","is-referenced-by-count":0,"title":["Sublingual Cyclobenzaprine (Tonmya) for Fibromyalgia"],"prefix":"10.58347","volume":"68","author":[{"name":"Editors from The Medical Letter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"37151","published-online":{"date-parts":[[2026,1,19]]},"container-title":["The Medical Letter on Drugs and Therapeutics"],"original-title":[],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:26:23Z","timestamp":1770063983000},"score":1,"resource":{"primary":{"URL":"https:\/\/secure.medicalletter.org\/TML-article-1746a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":0,"journal-issue":{"issue":"1746","published-online":{"date-parts":[[2026,1,19]]}},"URL":"https:\/\/doi.org\/10.58347\/tml.2026.1746a","relation":{},"ISSN":["1523-2859"],"issn-type":[{"value":"1523-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]}}}